MAPT and Alzheimer disease: One study demonstrated that quercetin-nanoparticle-loaded exosomes showed enhanced bioavailability with a therapeutic effect in Alzheimer’s disease by inhibiting cyclin-dependent kinase 5 (CDK5), facilitating tau protein phosphorylation [145].